1. science
2. medicine
3. psychology and psychiatry

 MENAMAT in collaboration with ECNP
is honored to introduce:
3rd ANNUAL INTERNATIONAL
MOOD AND ANXIETY TREATMENT
GUIDELINE CONGRESS
24 – 25 APRIL 2015
JW Marriott Marquis Hotel
DUBAI, UAE
In Association with:
I
It is with great pleasure that we announce the “MENAMAT 3rdAnnual International Mood and Anxiety Treatment Guideline Implementation Congress” which will be held on April 2015 at JW Marquis – Dubai. The Middle East is an integral part of world scientific progress. Guidelines for treatment in all branches of medicine are becoming the norm rather than the exception. The goal of this Congress is to help implement our first MENAMAT Depression guideline focusing on the management of psychiatric disorder, taking into consideration Middle East diversity, genetic compositions, metabolic and cultural differences. The Congress will utilize the expertise of ECNP and a diverse group of opinion leaders both from Europe and North America as well as Local experts .We will bring to the picture other Guidelines (NICE, PAB and WFSBP) to enhance our experience. ECNP is committed to ensuring that advances in the understanding of brain function and human behavior are translated into better treatments and enhanced public health. ECNP's goals • Support innovative research in the convergent disciplines of neuropsychopharmacology and facilitate the communication of ideas, discoveries and best practices. • Encourage the scientific activities of countries in Europe and co-­‐ordinate the development of common European standards. • Promote the entry of young scientists into the field and support their ongoing professional development. • Provide guidance and information to the public on matters relating to brain function and the treatment of brain disorders. • Facilitate dialogue with regulators, government bodies, international agencies and industry. The objective of this meeting is: Guideline Implementation • To look at an effective implementation strategy by strengthening the message of education of care teams and provides feedback of patient data to physicians. Help physicians write more appropriate prescriptions for antidepressants. • Continuing education as the sole intervention to promote adherence with guidelines and the use of evidence based medicine in the management of depression. That should not affect the diagnostic or communicative skills of psychiatrist/general practitioners (GPs). • To help launch good quality studies to determine the effects of implementation strategies in psychiatric services (e.g. feedback, academic detailing, reminders, and audits aimed at changing physician behavior) to promote adherence with evidence and guidelines on depression, anxiety, and bipolar disorder. • The effects of implementation depend on the context and nature of the change process. •
•
•
To teach the best practice in the evidence-­‐based treatment of major depression, bipolar disorder, and anxiety disorder. To clarify principles to create guidelines to the various cultures and countries of the Middle East and North Africa (MENAMAT). Finally, to build a collaborative group of leading clinicians and academic in the Middle East who will work with MENAMAT to improve the recognition and treatment of major psychiatric disorder. The features of this meeting special lectures and topics are: • Co-­‐morbidity of depression and anxiety disorder. • Managing compliance in depressed patients. • Managing affecting and anxiety disorders in clinical practice. • Update on bipolar etiology, diagnoses and treatment. • Update on new antidepressants. • Under-­‐diagnosis in bipolar patients. • Controversies in depression associated with medical illnesses. • Bipolar management between theory and clinical practice. • Management of anxiety disorders. • Anxiety case studies. • Management of depression with apathy and anhedonia. • Do we need guidelines for Middle East and North Africa: Current approach in practice. • Roadmap for developing Middle East and North Africa Guidelines (MENAMAT). We hereby would like to emphasize the importance of your partnership in this highly valued event. Your participation will undoubtedly contribute to the success of this Congress and will be highly appreciated. There are several modalities through which you can participate in the different activities of this scientific event. Any information required on your part will be gladly provided. I will be looking forward to your dynamic participation and support Sincerely yours, Dr. Hany Shafey Congress Chairman Plenary Speakers Prof. Guy Goodwin Professor of Psychiatry who specializes in the neurobiology of bipolar disorder. He is the current holder of the W A Handley Chair of Psychiatry at Oxford University. Prof. Tarek A. Okasha Professor of Psychiatry Institute of Psychiatry, Faculty of Medicine, Ain Shams University Secretary for Scientific Meetings, World Psychiatric Association Prof. Roger McIntyre Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. Prof. Driss Moussaoui Professor of Psychiatry and Human Sciences, Casablanca, Morocco Immediate past-­‐president of the World Association of Social Psychiatry. Prof. Hany Shafey Clinical Associate Professor of Psychiatry (Adj) University of Western Ontario Canada Consultant psychiatrist Dubai (Congress Co-­‐Chair) Dr. Raymond H. Hamden Ph.D. in Psychology and continued post-­‐graduate studies in Modern Psychoanalysis. Consultant in Clinical Psychology, Diplomate, American College of Forensic Examiners International. Washington DC, USA Planning Committee Prof. Mohammed Hasan Fayek Assistant Head Of Psychiatric Department Rashid Hospital Dubai, UAE Prof. Mohamed Khaled Consultant and Health of Psychiatric Department SGH-­‐ Jeddah Prof. Mahdi Abu-­‐Madini Associate Professor College of Medicine Department Psychiatry University of Dammam Saudi Arabia Prof. Tarek A. Okasha Professor of Psychiatry Institute of Psychiatry, Faculty of Medicine, Ain Shams University Secretary for Scientific Meetings, World Psychiatric Association Prof. Hany Shafey Clinical Associate Professor of Psychiatry (Adj) University of Western Ontario Canada Consultant psychiatrist Dubai (Congress Co-­‐Chair) Accreditation: 1-­‐ The European Accreditation Committee in CNS (EACIC) has granted 12.5 CME credits to this Congress. 2-­‐ 2-­‐United Arab Emirates Ministry of Health – 12 credits (12 credits for 2 days). Program – April 24/25/ 2015 MENAMAT Dubai Congress Agenda Day 1 09:00 -­‐ 09:15 Introduction & welcome (Prof H. Shafey, UAE & Prof G. Goodwin, UK) 09:15 -­‐ 10:00 Major Depressive Disorder: The Importance of a Domain Approach (Prof. Roger McIntyre, CAN) 10:00 -­‐ 10:15 Question Period (Prof. Roger McIntyre, CAN) 10:15 -­‐ 11:00 Achieving functional recovery in depressed patients (Prof. G. Goodwin, UK)
11:00 -­‐ 11:15 Question Period (Prof. Guy Goodwin, UK) 11:15 -­‐ 11:45 Coffee break 11:45 -­‐ 12:00 THE NEW FRAMEWORK FOR MENAMAT: Guidelines for the pharmacological treatment of anxiety disorders (Prof H. Shafey UAE/CAN) 12:30 -­‐ 12:45 Question Period (Prof H. Shafey UAE/CAN) 12:45 -­‐14:00 Lunch break 14:00 -­‐ 14:45 Polypharmacy in Psychiatry (Prof. T. Okasha, Egypt) 14:45 -­‐ 15:00 Question Period (Prof. T. Okasha, Egypt) WORKSHOP 15:00 -­‐ 16:30 Practical Challenges: Use of Depression Guidelines in clinical cases 16:30 -­‐ 17:00 Question Period (all) MENAMAT Dubai Congress Agenda Day 2 09:00 -­‐ 09:15 Introduction & welcome (Prof H. Shafey, UAE/CAN & Prof. G. Godwin, UK) 09:15 -­‐ 10:00 Cultural aspects of anxiety disorders (Prof. Driss Moussaoui/Morocco) 10:00 -­‐ 10:15 Question Period (Prof. Moussaoui) 10:15 -­‐ 11.00 Evidence-­‐based guidelines for treating bipolar disorder: revised third edition: Recommendations from the British Association for Psychopharmacology (Prof. Guy Goodwin, UK) 11:00 -­‐ 11:15 Question Period Prof. Guy Goodwin, UK) 11:15 -­‐ 11:45 Coffee break 11:45 -­‐ 12:30 Bipolar Disorder Improving Outcomes with Guideline Concordant Care (Prof. Roger McIntyre, CAN) 12:30 -­‐ 12:45 Question Period (Prof. Roger McIntyre, CAN) 12:45 -­‐ 14:00 Lunch Break 14:00 -­‐ 14:45 Culture conditioning and emotions (Raymond Hamden PhD) 14:45 -­‐ 15:00 Question Period (Raymond Hamdan PhD) WORKSHOP 15:00 -­‐ 16:30 Practical Challenges: Use of Bipolar Guidelines in clinical cases 16:30 -­‐ 17:00 Question Period (all) Registration Fees: First early Bird
Deadline
28th Feb 2015
Second early Bird
Deadline
31st March 2015
On Site
Physician
USD 600
USD 700
USD 800
Allied Health Care
Professional
USD 450
USD 550
USD 600
Resident
USD 400
USD 450
USD 550
Student
USD 200
USD 300
USD 400
I
BrandMomentumArabia is the official organizer of this Congress.